Artikel von Jörg Meyer
Jörg Meyer is a graduate economist and has been involved with the stock market since 2001. Since 2005, he has been a trader focusing on American and German stocks. He follows a technical-fundamental approach to identify the best stories and trading ideas. At TraderFox, he is responsible for the flagship trading offering "Trading Room" as well as the sections "Germany/Europe" and "USA".
Latest from Jörg Meyer
Apple: The Operational Turning Point is Here. AI Siri Will Monetize 2.5 Billion Devices and the Product Pipeline is Innovative!
HSBC analysts have upgraded Apple from Hold to Buy and raised the price target from $260 to $366....
Schlumberger is the Hottest Story in the oil Sector in my Opinion!
The Iran War caused the price of Brent oil to rise from below $70 to over $115 from early to mid-March....
AI Triggers an Innovation-Driven Growth Phase in the Biotech Sector. Two Leading Stocks Aae Moving Onto the Watchlist for our US Portfolio!
We have successfully invested in AI infrastructure stocks. Now, we see biotechnology as a future beneficiary...
Two Favorites to Represent the Humanoid Robotics Mega Market. One Stock is on the Watchlist for our US Portfolio!
The "WSJ" reported an exciting development regarding Xpeng today. This is the Chinese challenger to Tesla,...
Jabil Will be the Contract Manufacturer for Humanoids. I Plan to buy Shares for two Reasons!
Xpeng had exciting news today, announcing that by the end of 2026, it aims to have a production capacity...
Technotrans Has Double-Digit Million Orders for Data Center Cooling Solutions. Here's why the Big Volume Business is Still to Come!
Technotrans (i) announces success. According to the company, order intake in the Data Center business...
XPeng: This Chinese Tesla Challenger Aims to Build 1,000 Humanoid Robots per Month. Global Deployment of IRON Begins in 2027!
The Chinese electric vehicle manufacturer XPeng is pushing to enter the robotics sector and plans...
ASML: CEO Fouquet Sees Uninterrupted Demand for EUV Systems. These are the Drivers Behind Wednesday's Forecast Increase for 2026!
ASML significantly exceeds market expectations in the second quarter with a revenue of €9.33 billion...
Crowdstrike: IBM Sounds the Alarm, but This Security Giant Benefits from Fear!
A recent statement from IBM highlights how much cybersecurity concerns are currently redirecting traditional...
Dell: Three Reasons Why the Trending Value P/S Stock Will Take Off Again!
My impression is that the upturn in AI infrastructure stocks has not yet reached its peak. They completely...
There are Several Reasons Why the AI Infrastructure Trade is Restarting. Traders Must Know These Top 3 Leader Stocks!
The chances are growing that the upswing in AI infrastructure stocks has not yet reached its peak. Optimistic...
The IBM Stock Collapses by 20%. A Statement on Changed Customer Buying Patterns Initiates the Next SaaSocalypse
Preliminary quarterly figures and changing customer buying patterns weigh on IBM. The stock falls...
IONOS: AI Solutions for SMEs Could Trigger a Revaluation. Here's why BofA Sets a Price Target of €37!
AI infrastructure stocks are correcting. Capital is rotating into the values of the narrative "AI losers"....
Arista Networks: Meta Invests $50 billion into the Hyperion Data Center, and This Stock is the Ultimate Beneficiary
Meta (i) is spending a capex of $145 billion this year. According to Morgan Stanley, this could rise...
Basler and Siltronic are two Stocks with High Trend Strength. Here’s the Story behind them!
Leader stocks can be identified by their trend strength and proximity to the 52-week high. Especially...
Carl Zeiss: Historically Cheap with a P/E Ratio of 14.2 - is it Time for a Comeback?
The success-favored Carl Zeiss Meditec has been experiencing a pronounced earnings dip in recent years....
Meta: no Signs of Overcapacity. The Hyperion Data Center is set to Encompass 5 GW and Cost $50 Billion!
Meta Platforms is expanding its future Hyperion data center in Louisiana to a total capacity of 5...
Carl Zeiss: Historically cheap with a P/E28e of 14.2 - Is it time for the comeback?
The successful Carl Zeiss Meditec has experienced a significant downturn in earnings in recent years....
BB Biotech: Our new core position in the biotech sector. AI will generate new therapies and accelerate R&D processes.
Since the end of 2022, the investment trend "AI" has focused on chip stocks, memory providers, and network...
AXA: The AI Winner Valued as a Value Stock with a P/E of 10
The first phase of the AI rally belonged to infrastructure stocks, namely the manufacturers of chips,...